Mirvetuximab soravtansine has activity in platinum-sensitive epithelial ovarian cancer

Nature Reviews Clinical Oncology, Published online: 25 March 2024; doi:10.1038/s41571-024-00888-wMirvetuximab soravtansine has activity in platinum-sensitive epithelial ovarian cancer

Source: Nature Reviews Clinical Oncology - March 25, 2024 Category: Cancer & Oncology Authors: Diana Romero Source Type: research